scispace - formally typeset
J

Jerzy Sadowski

Researcher at Jagiellonian University Medical College

Publications -  286
Citations -  9986

Jerzy Sadowski is an academic researcher from Jagiellonian University Medical College. The author has contributed to research in topics: Aortic valve replacement & Aortic valve. The author has an hindex of 31, co-authored 280 publications receiving 9235 citations. Previous affiliations of Jerzy Sadowski include University of Maryland, Baltimore & University of Oxford.

Papers
More filters
Journal ArticleDOI

Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): A randomised controlled trial

TL;DR: Catheter-based renal denervation can safely be used to substantially reduce blood pressure in treatment-resistant hypertensive patients and should be continued, according to the authors.
Journal ArticleDOI

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study

TL;DR: In this article, a proof-of-principle trial of therapeutic renal sympathetic denervation in patients with resistant hypertension (i.e., systolic blood pressure ≥160 mm/hg on three or more antihypertensive medications, including a diuretic) was conducted to assess safety and blood-pressure reduction effectiveness.
Journal ArticleDOI

Mechanisms of Increased Vascular Superoxide Production in Human Diabetes Mellitus Role of NAD(P)H Oxidase and Endothelial Nitric Oxide Synthase

TL;DR: These observations suggest important roles for NAD(P)H oxidases, endothelial NO synthase uncoupling, and protein kinase C signaling in mediating increased vascular superoxide production and endothelial dysfunction in human diabetes mellitus.
Journal ArticleDOI

Coronary Artery Superoxide Production and Nox Isoform Expression in Human Coronary Artery Disease

TL;DR: Increased expression and activity of NAD(P)H oxidase subunits and xanthine oxidase, in part mediated through angiotensin II and PKC-dependent pathways, are important mechanisms underlying increased oxidative stress in human coronary artery disease.